The advantages of aminolevulinic acid photodynamic therapy in dermatology

Journal of Dermatological Treatment

Volumn 13, Issue SUPPL. 1, 2002, Pages

  Taylor, E L ^a   Brown, S B ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Aminolevulinic acid; Dermatology; Photodynamic; Photosensitizer

Indexed keywords

AMINOLEVULINIC ACID; ESTER DERIVATIVE; PHOTOFRIN; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN;

ACTINIC KERATOSIS; BLUE LIGHT; BOWEN DISEASE; DERMATOLOGY; DRUG EFFECT; DRUG INDICATION; DRUG MECHANISM; ONCOLOGY; PHOTOCHEMOTHERAPY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PSORIASIS; REVIEW; TECHNIQUE;

EID: 0036081195     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/095466302317414645     Document Type: Review

References (44)

1. A history of photodynamic therapy
2. Seasonal affective-disorder - A description of the syndrome and preliminary findings with light therapy
3. Treatment of seasonal affective-disorder with light in the evening
4. Influence of light on the hyperbilirubinaemia of infants
5. Photochemotherapy of psoriasis with oral methoxsalin and long wave ultraviolet light
6. On the diffusion length of singlet oxygen in cells and tissues
7. Studies to assess the potential of photodynamic therapy for the treatment of bronchial carcinomas
8. Studies on the formation of phycocyanin, porphyrins, and a blue phycobilin by wild-type and mutant strains of Cyanidium caldarium
9. 5-Aminolevulinic acid-based photodynamic therapy: Principles and experimental research
10. Photodynamic therapy with endogenous protoporphyrin IX: Basic principles and present clinical experience
11. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence
12. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolevulinic acid hexyl ester-induced protoporphyrin IX: A pilot study
13. Inhalation of 5-aminolevulinic acid: A new technique for flourescence detection of early stage lung cancer
14. Comparison of the pharmacokinetics and phototoxicity of protoporphyrin IX metabolized from 5-aminolevulinic acid and two derivatives in human skin in vivo
15. Preferential porphyrin enrichment in solar keratoses upon topical application of δ-aminolevulinic acid methylester
16. 5-Aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters
17. Endogenous protoporphyrin IX, A clinically useful photosensitiser for photodynamic therapy
18. Effects of photodynamic therapy with topical application of 5-aminolevulinic acid on normal skin of hairless guinea pigs
19. Topical PDT with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses-superficial squamous cell carcinomas and basal cell carcinomas?
20. Superficial photodynamic therapy with topical 5-aminolevulinic acid for superficial primary and secondary skin cancer
21. Iontophoretic delivery of ALA provides a quantitative model for ALA pharmacokinetics and PpIX phototoxicity in human skin
22. Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: A one-year follow-up study
23. Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethyl-sulphoxide and ethylendiaminetetraacetic acid: A comparison of two light sources
24. Modified topical photodynamic therapy of superficial skin tumours, utilizing aminolevulinic acid, penetration enhancers, red light, and hyperthermia
25. Photosensitization of pancreatic tumour cells by delta-aminolaevulinic acid esters
26. 5-Aminolevulinic acid and its derivatives: Physical chemical properties and protoporphyrin IX formation in cultured cells
27. Routine double treatments of superficial basal cell carcinomas using aminolevulinic acid-based photodynamic therapy
28. Photodynamic therapy based on 5-aminolevulinic acid: Applications in dermatology
29. Large patches of Bowen's disease treated by topical aminolevulinic acid photodynamic therapy
30. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical δ-aminolevulinic acid sensitization and laser irradiation
31. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease
32. Repetitive photodynamic therapy with topical δ-aminolevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours
33. Photodynamic therapy of epithelial skin tumours using delta-aminolevulinic acid and desferrioxamine
34. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical δ-aminolevulinic acid photodynamic therapy
35. Photodynamic therapy of superficial basal cell carcinomas using topical 5-aminolevulinic acid in a nanocolloid lotion
36. Photodynamic therapy of superficial basal cell carcinoma by instillation of aminolevulinic acid and irradiation with visible light
37. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid
38. The variable response of plaque psoriasis after a single treatment with topical 5-aminolaevulinic acid and photodynamic therapy
39. Topical photodynamic therapy using methylene blue and 5-aminolevulinic acid in psoriasis
40. The accumulation of protoporphyrin IX in plaque psoriasis after topical application of 5-aminolevulinic acid indicates a potential for superficial photodynamic therapy
41. The establishment of treatment parameters for ALA-PDT of plaque psoriasis
42. Treatment of psoriasis by topical photodynamic therapy with polychromatic light
43. Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy
44. PDT in dermatology